Patent details

EP2504349 Title: METHOD OF PURIFYING PEGYLATED PROTEINS

Basic Information

Publication number:
EP2504349
PCT Application Number:
EP2010068112
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107847691
PCT Publication Number:
WO2011064247
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD OF PURIFYING PEGYLATED PROTEINS
French Title of Invention:
PROCÉDÉ DE PURIFACTION DE PROTÉINES PEGYLÉES
German Title of Invention:
VERFAHREN ZUR AUFREINIGUNG VON PEGYLIERTEN PROTEINEN
SPC Number:

Dates

Filing date:
24/11/2010
Grant date:
26/02/2020
EP Publication Date:
03/10/2012
PCT Publication Date:
03/06/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/02/2020
EP B1 Publication Date:
26/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/11/2020
Expiration date:
24/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/02/2020
 
 

Name:
Novo Nordisk Health Care AG
Address:
Andreasstrasse 15, 8050 Zürich, Switzerland (CH)

Inventor

1

Name:
SEJERSGAARD, Lars
Address:
Denmark (DK)

2

Name:
BOGSNES, Are
Address:
Denmark (DK)

3

Name:
WIENDAHL, Matthias, Karl, Dietrich
Address:
Denmark (DK)

Priority

1

Priority Number:
09176881
Priority Date:
24/11/2009
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
264486 P
Priority Date:
25/11/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/48; C07K 1/18; C12N 9/64; A61K 47/60;

Publication

European Patent Bulletin

Issue number:
202009
Publication date:
26/02/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages